Cargando…
1692P SARS-CoV-2 RNA testing in cancer patients treated at a Department of Medical Oncology in Vienna, Austria
Autores principales: | Berghoff, A.S., Gansterer, M., Bathke, A.C., Trutschnig, W., Hungerländer, P., Berger, J.M., Kreminger, J., Starzer, A., Schmidt, R., Lamm, W., Raderer, M., Gottlieb, A.D., Mauser, N.J., Preusser, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506345/ http://dx.doi.org/10.1016/j.annonc.2020.08.1756 |
Ejemplares similares
-
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic: Conclusions for crisis response at a high-volume oncology center
por: Berger, Julia M., et al.
Publicado: (2021) -
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
por: Mair, Maximilian J., et al.
Publicado: (2022) -
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
por: Mair, Maximilian J., et al.
Publicado: (2022) -
Immune escape mechanisms and therapeutic approaches in cancer: the cancer-immunity cycle
por: Starzer, Angelika M., et al.
Publicado: (2022) -
Mr Ernst Woller President of the State Parliament of Vienna Austria
por: Ordan, Julien
Publicado: (2019)